肌少症标准化生物样本和数据库建设中国专家共识  

Chinese expert consensus on standardized biobanking of biospecimen and database construction for sarcopenia

作　　者：中国医药生物技术协会组织生物样本库分会 上海交通大学医学院附属仁济医院 翁玉蓉[2] 胡耀敏[2] 康晓楠[3] 张小燕[4] Biobank Branch,China Medicinal Biotech Association;Renji Hospital,Shanghai Jiaotong University School of Medicine

机构地区：[1]不详 [2]上海交通大学医学院附属仁济医院老年医学科 [3]上海交通大学医学院附属仁济医院生物资源中心 [4]生物芯片上海国家工程研究中心

出　　处：《中国医药生物技术》2024年第5期480-488,共9页Chinese Medicinal Biotechnology

摘　　要：随着人口老龄化的不断加剧,肌少症患病率持续增高,肌少症标准化生物样本和数据库的建设对于进一步加深疾病研究及转化应用至关重要。由于目前国内外在此领域尚未建立统一共识,中国医药生物技术协会组织生物样本库分会、上海交通大学医学院附属仁济医院老年医学科和生物样本资源中心联合全国老年医学领域、生物样本领域、衰老基础与临床研究领域的专家制订了本共识,旨在推动肌少症高质量生物样本和数据库的建设,以促进肌少症研究、精准诊治和临床转化。With the aging of the population,the morbidity of sarcopenia continues to increase.The construction of standardized biobanking of biospecimen and databases for sarcopenia is crucial for further deepening research and facilitating translational application of the disease.Due to the absence of unified consensus in this field in China and abroad,Biobank Branch of China Medicinal Biotech Association,Department of Geriatrics and Biological Resource Center of Renji Hospital-Shanghai Jiao Tong University School of Medicine have jointly formulated this consensus with experts in the field of geriatrics,biobanking management,and basic and clinical research on aging,aiming to promote the construction of high-quality biobank and database for sarcopenia,so as to promote sarcopenia research,precision diagnosis and treatment and clinical transformation.

关 键 词：肌少症 生物样本 数据库 专家共识 

分 类 号：R685[医药卫生—骨科学]